measles
play

Measles Disclosures I have no disclosures Meg Fisher, MD Medical - PDF document

Measles Disclosures I have no disclosures Meg Fisher, MD Medical Director I may be mentioning off label uses of drugs Measles Objectives RNA virus: family Paramyxoviridae, genus Morbillivirus Recognize measles Transmitted by


  1. Measles Disclosures • I have no disclosures Meg Fisher, MD Medical Director • I may be mentioning off label uses of drugs Measles Objectives • RNA virus: family Paramyxoviridae, genus Morbillivirus • Recognize measles • Transmitted by droplets and air • Manage a child with measles • Extremely contagious • Prevent transmission • Incubation period 8 to 12 days • Advise families regarding measles • Contagious 4 days prior to 4 days immunization after the rash appears Measles in the US Measles in the US • 1 st Vaccine • 2014: over 600 cases and licensed 23 outbreaks 1963 • US travelers bring measles home • About 95% • Travelers to US bring measles along effective • Secondary spread to unimmunized • US measles free since contacts 2000 1

  2. 2015 Outbreak Clinical Illness • Fever, cough, conjunctivitis • Day 2 to 3 of fever, Koplik spots appear • One to 3 days later, rash appears on the face, maculopapular to confluent • Rash spreads and then fads over days Koplik spots Fever, Cough, Conjunctivitis Confluent Rash Complications • Otitis media • Respiratory: pneumonia (viral and bacterial); laryngotracheitis • Encephalitis • Subacute sclerosing panencephalitis 2

  3. Treatment Diagnosis • Clinical • Isolate the patient: air and droplet • Confirm with serology: IgG and IgM • Report the case • Virus isolation: nasopharyngeal swab, urine • Vitamin A: Once daily for two days • Report all suspected cases: 200,000 IU age > 12 mo; 100,000 IU local health department – 6 ‐ 11 mo; 50,000 IU < 6 mo if not available, call the state • Ribavirin: in vitro, not approved daytime: (609) 826 ‐ 5964 after hours: (609) 392 ‐ 2020 Prevention Infection Control • Measles vaccine: MMR • Staff: all should be immune • Proof of immunity: seropositive; 2 doses Routine: 12 ‐ 15 mo, 4 ‐ 6 yr • Born 1957 and later: seropositive or 2 doses of Post ‐ exposure: within 72 hours vaccine at least 28 days apart • Immunoglobulin 0.25 ml/kg (max 15) • Born before 1957: generally considered • Travelers/outbreaks: MMR for ages 6 immune but serology recommended; vaccine to 12 mo; child: give 2 nd dose if not seropositive Take Home Messages Infection Control • Think measles: fever, cough, • Triage is essential conjunctivitis and then rash • When possible, make the diagnosis outside of your office: car or hospital • Notify local health department stat • If the child is in your office, put into a room • Get the proper specimens: serology • Mask on the child if possible and viral culture (NP preferred) • The area is considered contaminated for 2 hours after the patient leaves • Get everyone protected and immunized: staff and patients • Airflow in the office: air may be re ‐ circulated 3

  4. Questions • My special thanks to Barbara Montana, MD for help reviewing my slides. She will help me answer your questions • Thank you for listening – the program will be available for viewing in the future • If you have additional questions, please send them to cmott@njaap.org 4

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend